Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1999 Oct;107(Suppl 5):681–686. doi: 10.1289/ehp.99107s5681

Gender and risk of autoimmune diseases: possible role of estrogenic compounds.

S A Ahmed 1, B D Hissong 1, D Verthelyi 1, K Donner 1, K Becker 1, E Karpuzoglu-Sahin 1
PMCID: PMC1566250  PMID: 10502531

Abstract

A striking common feature of many autoimmune diseases in humans and experimental animals, despite differences in pathology, is that females are highly susceptible to autoimmune conditions compared to males. In several animal models, estrogens promote, whereas androgens abrogate, B-cell-mediated autoimmune diseases. To understand mechanisms by which estrogens regulate autoimmunity, it is first necessary to decipher estrogen effects on the normal immune system. Estrogen treatment of nonautoimmune mice diminished lymphocyte numbers in both developmental and mature lymphoid organs. Estrogen dysregulated T- and B-cell balance by inducing selective T-cell hypoactivity and B-cell hyperactivity. Even though estrogen did not alter the relative percentages of splenic T-cell subsets, splenic lymphocytes had a reduced proliferative response to T-cell stimulants and were refractory to rescue from activation-induced apoptosis compared to cells from placebo-treated mice. In contrast, estrogen induced B-cell hyperactivity (promoted autoantibodies to double-stranded DNA and phospholipids, increased numbers of plasma cells, and increased autoantibody yield per B cell). Note that treatment of normal mice with estrogen can alter T- and B-cell regulation and overcome B-cell tolerance to result in autoimmunity in normal individuals. Could environmental estrogens promote some human autoimmune disorders? Is there a link between environmental estrogens and autoimmune disorders, especially since these disorders are reported possibly more frequently? These provocative questions warrant investigation. Our findings on immunomodulatory effects may serve as a benchmark to examine whether endocrine-disrupting chemicals will have similar immunologic effects.

Full text

PDF
681

Images in this article

683Figure 1
on p.683
684Figure 2
on p.684

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed S. A., Talal N. Sex hormones and the immune system--Part 2. Animal data. Baillieres Clin Rheumatol. 1990 Apr;4(1):13–31. doi: 10.1016/s0950-3579(05)80241-9. [DOI] [PubMed] [Google Scholar]
  2. Ahmed S. A., Verthelyi D. Antibodies to cardiolipin in normal C57BL/6J mice: induction by estrogen but not dihydrotestosterone. J Autoimmun. 1993 Jun;6(3):265–279. doi: 10.1006/jaut.1993.1023. [DOI] [PubMed] [Google Scholar]
  3. Ansar Ahmed S., Penhale W. J., Talal N. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol. 1985 Dec;121(3):531–551. [PMC free article] [PubMed] [Google Scholar]
  4. Baird D. D., Wilcox A. J., Herbst A. L. Self-reported allergy, infection, and autoimmune diseases among men and women exposed in utero to diethylstilbestrol. J Clin Epidemiol. 1996 Feb;49(2):263–266. doi: 10.1016/0895-4356(95)00521-8. [DOI] [PubMed] [Google Scholar]
  5. Carlsten H., Tarkowski A., Holmdahl R., Nilsson L. A. Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin Exp Immunol. 1990 Jun;80(3):467–473. doi: 10.1111/j.1365-2249.1990.tb03311.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Da Silva J. A., Larbre J. P., Seed M. P., Cutolo M., Villaggio B., Scott D. L., Willoughby D. A. Sex differences in inflammation induced cartilage damage in rodents. The influence of sex steroids. J Rheumatol. 1994 Feb;21(2):330–337. [PubMed] [Google Scholar]
  7. Dalal M., Kim S., Voskuhl R. R. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J Immunol. 1997 Jul 1;159(1):3–6. [PubMed] [Google Scholar]
  8. Dayan M., Zinger H., Kalush F., Mor G., Amir-Zaltzman Y., Kohen F., Sthoeger Z., Mozes E. The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations. Immunology. 1997 Jan;90(1):101–108. doi: 10.1046/j.1365-2567.1997.00122.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fitzpatrick F., Lepault F., Homo-Delarche F., Bach J. F., Dardenne M. Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse. Endocrinology. 1991 Sep;129(3):1382–1390. doi: 10.1210/endo-129-3-1382. [DOI] [PubMed] [Google Scholar]
  10. Gilmore W., Weiner L. P., Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol. 1997 Jan 1;158(1):446–451. [PubMed] [Google Scholar]
  11. Grossman C. J. Regulation of the immune system by sex steroids. Endocr Rev. 1984 Summer;5(3):435–455. doi: 10.1210/edrv-5-3-435. [DOI] [PubMed] [Google Scholar]
  12. Gulino A., Screpanti I., Torrisi M. R., Frati L. Estrogen receptors and estrogen sensitivity of fetal thymocytes are restricted to blast lymphoid cells. Endocrinology. 1985 Jul;117(1):47–54. doi: 10.1210/endo-117-1-47. [DOI] [PubMed] [Google Scholar]
  13. Herbst A. L., Ulfelder H., Poskanzer D. C. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971 Apr 15;284(15):878–881. doi: 10.1056/NEJM197104222841604. [DOI] [PubMed] [Google Scholar]
  14. Jacobson D. L., Gange S. J., Rose N. R., Graham N. M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997 Sep;84(3):223–243. doi: 10.1006/clin.1997.4412. [DOI] [PubMed] [Google Scholar]
  15. Jo T., Terada N., Saji F., Tanizawa O. Inhibitory effects of estrogen, progesterone, androgen and glucocorticoid on death of neonatal mouse uterine epithelial cells induced to proliferate by estrogen. J Steroid Biochem Mol Biol. 1993 Jul;46(1):25–32. doi: 10.1016/0960-0760(93)90205-b. [DOI] [PubMed] [Google Scholar]
  16. Kalland T. Exposure of neonatal female mice to diethylstilbestrol persistently impairs NK activity through reduction of effector cells at the bone marrow level. Immunopharmacology. 1984 Apr;7(2):127–134. doi: 10.1016/0162-3109(84)90062-6. [DOI] [PubMed] [Google Scholar]
  17. Kalland T., Strand O., Forsberg J. G. Long-term effects of neonatal estrogen treatment on mitogen responsiveness of mouse spleen lymphocytes. J Natl Cancer Inst. 1979 Aug;63(2):413–421. [PubMed] [Google Scholar]
  18. Kato K., Chen Y., Nakane A., Minagawa T., Fujieda K., Kimura T., Yamamoto K. Suppression of delayed-type hypersensitivity in mice pretreated with diethylstilbesterol: involvement of sex hormones in immunomodulation. J Leukoc Biol. 1988 Jun;43(6):530–538. doi: 10.1002/jlb.43.6.530. [DOI] [PubMed] [Google Scholar]
  19. Kavlock R. J., Daston G. P., DeRosa C., Fenner-Crisp P., Gray L. E., Kaattari S., Lucier G., Luster M., Mac M. J., Maczka C. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ Health Perspect. 1996 Aug;104 (Suppl 4):715–740. doi: 10.1289/ehp.96104s4715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kong L., Ogawa N., Nakabayashi T., Liu G. T., D'Souza E., McGuff H. S., Guerrero D., Talal N., Dang H. Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum. 1997 Jan;40(1):87–97. doi: 10.1002/art.1780400113. [DOI] [PubMed] [Google Scholar]
  21. Lahita R. G. Sex hormones and the immune system--Part 1. Human data. Baillieres Clin Rheumatol. 1990 Apr;4(1):1–12. doi: 10.1016/s0950-3579(05)80240-7. [DOI] [PubMed] [Google Scholar]
  22. Li Z. G., Danis V. A., Brooks P. M. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol. 1993 Mar-Apr;11(2):157–162. [PubMed] [Google Scholar]
  23. Marselos M., Tomatis L. Diethylstilboestrol: I, Pharmacology, Toxicology and carcinogenicity in humans. Eur J Cancer. 1992;28A(6-7):1182–1189. doi: 10.1016/0959-8049(92)90482-h. [DOI] [PubMed] [Google Scholar]
  24. Marselos M., Tomatis L. Diethylstilboestrol: II, pharmacology, toxicology and carcinogenicity in experimental animals. Eur J Cancer. 1992;29A(1):149–155. doi: 10.1016/0959-8049(93)90597-9. [DOI] [PubMed] [Google Scholar]
  25. McMartin K. E., Kennedy K. A., Greenspan P., Alam S. N., Greiner P., Yam J. Diethylstilbestrol: a review of its toxicity and use as a growth promotant in food-producing animals. J Environ Pathol Toxicol. 1978 Jan-Feb;1(3):279–313. [PubMed] [Google Scholar]
  26. Muller D., Chen M., Vikingsson A., Hildeman D., Pederson K. Oestrogen influences CD4+ T-lymphocyte activity in vivo and in vitro in beta 2-microglobulin-deficient mice. Immunology. 1995 Oct;86(2):162–167. [PMC free article] [PubMed] [Google Scholar]
  27. Newbold R. R., Bullock B. C., McLachlan J. A. Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res. 1990 Dec 1;50(23):7677–7681. [PubMed] [Google Scholar]
  28. Noller K. L., Blair P. B., O'Brien P. C., Melton L. J., 3rd, Offord J. R., Kaufman R. H., Colton T. Increased occurrence of autoimmune disease among women exposed in utero to diethylstilbestrol. Fertil Steril. 1988 Jun;49(6):1080–1082. doi: 10.1016/s0015-0282(16)59965-8. [DOI] [PubMed] [Google Scholar]
  29. Okuyama R., Abo T., Seki S., Ohteki T., Sugiura K., Kusumi A., Kumagai K. Estrogen administration activates extrathymic T cell differentiation in the liver. J Exp Med. 1992 Mar 1;175(3):661–669. doi: 10.1084/jem.175.3.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Olsen N. J., Kovacs W. J. Case report: testosterone treatment of systemic lupus erythematosus in a patient with Klinefelter's syndrome. Am J Med Sci. 1995 Oct;310(4):158–160. doi: 10.1097/00000441-199510000-00006. [DOI] [PubMed] [Google Scholar]
  31. Olsen N. J., Kovacs W. J. Gonadal steroids and immunity. Endocr Rev. 1996 Aug;17(4):369–384. doi: 10.1210/edrv-17-4-369. [DOI] [PubMed] [Google Scholar]
  32. Piccinni M. P., Giudizi M. G., Biagiotti R., Beloni L., Giannarini L., Sampognaro S., Parronchi P., Manetti R., Annunziato F., Livi C. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol. 1995 Jul 1;155(1):128–133. [PubMed] [Google Scholar]
  33. Roubinian J. R., Talal N., Greenspan J. S., Goodman J. R., Siiteri P. K. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med. 1978 Jun 1;147(6):1568–1583. doi: 10.1084/jem.147.6.1568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Shelby M. D., Newbold R. R., Tully D. B., Chae K., Davis V. L. Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environ Health Perspect. 1996 Dec;104(12):1296–1300. doi: 10.1289/ehp.961041296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Staples J. E., Fiore N. C., Frazier D. E., Jr, Gasiewicz T. A., Silverstone A. E. Overexpression of the anti-apoptotic oncogene, bcl-2, in the thymus does not prevent thymic atrophy induced by estradiol or 2,3,7, 8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol. 1998 Jul;151(1):200–210. doi: 10.1006/taap.1998.8446. [DOI] [PubMed] [Google Scholar]
  36. Szekeres-Bartho J., Szekeres G., Debre P., Autran B., Chaouat G. Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody. Cell Immunol. 1990 Feb;125(2):273–283. doi: 10.1016/0008-8749(90)90083-4. [DOI] [PubMed] [Google Scholar]
  37. Szekeres-Bartho J., Wegmann T. G. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol. 1996 Aug;31(1-2):81–95. doi: 10.1016/0165-0378(96)00964-3. [DOI] [PubMed] [Google Scholar]
  38. Teixeira C., Reed J. C., Pratt M. A. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 1995 Sep 1;55(17):3902–3907. [PubMed] [Google Scholar]
  39. Verthelyi D. I., Ahmed S. A. Estrogen increases the number of plasma cells and enhances their autoantibody production in nonautoimmune C57BL/6 mice. Cell Immunol. 1998 Nov 1;189(2):125–134. doi: 10.1006/cimm.1998.1372. [DOI] [PubMed] [Google Scholar]
  40. Verthelyi D., Ahmed S. A. 17 beta-estradiol, but not 5 alpha-dihydrotestosterone, augments antibodies to double-stranded deoxyribonucleic acid in nonautoimmune C57BL/6J mice. Endocrinology. 1994 Dec;135(6):2615–2622. doi: 10.1210/endo.135.6.7988450. [DOI] [PubMed] [Google Scholar]
  41. Verthelyi D., Ansar Ahmed S. Characterization of estrogen-induced autoantibodies to cardiolipin in non-autoimmune mice. J Autoimmun. 1997 Apr;10(2):115–125. doi: 10.1006/jaut.1996.0121. [DOI] [PubMed] [Google Scholar]
  42. Vidal S., Gelpí C., Rodríguez-Sánchez J. L. (SWR x SJL)F1 mice: a new model of lupus-like disease. J Exp Med. 1994 May 1;179(5):1429–1435. doi: 10.1084/jem.179.5.1429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Wingard D. L., Turiel J. Long-term effects of exposure to diethylstilbestrol. West J Med. 1988 Nov;149(5):551–554. [PMC free article] [PubMed] [Google Scholar]
  44. van Vollenhoven R. F., Engleman E. G., McGuire J. L. An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum. 1994 Sep;37(9):1305–1310. doi: 10.1002/art.1780370906. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES